1. Home
  2. SNSC vs ELUT Comparison

SNSC vs ELUT Comparison

Compare SNSC & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SNSC

SunScout Holding Limited Class A Ordinary Shares

N/A

Current Price

$1.08

Market Cap

51.4M

Sector

N/A

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.83

Market Cap

42.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNSC
ELUT
Founded
N/A
2015
Country
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.4M
42.5M
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
SNSC
ELUT
Price
$1.08
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
665.1K
54.4K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.77
EPS
N/A
N/A
Revenue
N/A
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$0.50
52 Week High
$3.07
$1.51

Technical Indicators

Market Signals
Indicator
SNSC
ELUT
Relative Strength Index (RSI) 19.78 44.29
Support Level N/A $0.84
Resistance Level $1.70 $1.04
Average True Range (ATR) 0.30 0.08
MACD -0.04 -0.01
Stochastic Oscillator 4.19 19.92

Price Performance

Historical Comparison
SNSC
ELUT

About SNSC SunScout Holding Limited Class A Ordinary Shares

SunScout Holding Ltd is a clean-technology company engaged in the design, development, manufacturing, and commercialization of autonomous, solar-powered robotic mowers and related solar energy solutions. Its products are intended as alternatives to petrol-powered and grid-dependent electric lawn mowing equipment. The company's business comprises three lines of products and solutions, which are also its reportable segments: SunScout Products, Solar Power Development Solutions, and Engineering Products and Services. The majority of revenue is derived from the Solar Power Development Solutions segment, which develops and installs solar-energy systems for commercial, industrial, and institutional customers through EPC contracts. Geographically, maximum revenue is derived from New Zealand.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: